Antisense activity of an anti-HIV oligonucleotide conjugated to linear and branched high molecular weight polyethylene glycols

Farmaco

Volumn 53, Issue 10-11, 1998, Pages 634-637

  Bonora, Gian Maria ^a,e   Tocco, Graziella ^a   Zaramella, Simone ^b   Veronese, Francesco Maria ^b   Pliasunova, Olga ^c   Pokrovsky, Andrey ^c   Ivanova, Eugenia ^d   Zarytova, Valentina ^d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Dipto di Scienze Farmaceutiche   (Italy)

^c Institute of Molecular Virology   (Russian Federation)

^d INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antisense; HIV; Oligonucleotide; Polyethylene glycol

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MACROGOL DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONJUGATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR WEIGHT;

ANTI-HIV AGENTS; CELL SURVIVAL; CELLS, CULTURED; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR WEIGHT; OLIGONUCLEOTIDES, ANTISENSE; POLYETHYLENE GLYCOLS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032460829     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00078-0     Document Type: Article

References (14)

1. P.C. Zamecnik, M.L. Stephenson, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxyribonucleotide, Proc. Natl. Acad. Sci. USA 75 (1978) 280-284.
2. C.A. Stein, Y.-C. Cheng, Antisense oligonucleotide as therapeutic agent. Is the bullet really magic?, Science 261 (1993) 1004-1012.
3. S. Agrawal, Antisense oligonucleotides: a possible approach for chemotherapy of AIDS, in: E. Wickstrom (Ed.), Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS, Wiley, New York, 1991.
4. A. De Mesmaeker, R. Haener, P. Martin, H.E. Moser, Antisense oligonucleotides, Acc. Chem. Res. 28 (1995) 366-374.
5. S.T. Crooke, C.F. Bennet, Progress in antisense oligonucleotide therapeutics, Annu. Rev. Pharmacol. Toxicol. 36 (1996) 107-129.
6. G.M. Bonora, E. Ivanova, V. Zarytova, B. Burcovich, F.M. Veronese, Synthesis and characterization of high-molecular mass polyethylene glycol conjugated oligonucleotides, Bioconjugate Chem. 8 (1997) 89-93, and Refs. therein.
7. F.P. Svinarchuk, D.A. Konevetz, O.A. Pliasunova, A.G. Pokrovsky, V.V. Vlassov, Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophylic groups, Biochimie 75 (1993) 49-54.
8. S.G. Lokhov, M.A. Podyminogin, D.S. Sergeev, V.N. Silnikov, I.V. Kutyavin, G.V. Shishkin, V.P. Zarytova, Synthesis and high stability of complementary complexes of N-(2-hydroxyethyl) phenazinium derivatives of oligonucleotides, Bioconjugate Chem. 3 (1992) 414-419.
9. D.V. Pyshnyi, I.A. Pyshnaya, S.G. Lokhov, E.M. Ivanova, V.F. Zarytova, Mini-antisense oligonucleotides, Nucleosides Nucleotides 16 (1997) 1565-1569.
10. A.G. Pokrovsky, O.A. Pliasunova (1997) personal communication.
11. G.M. Bonora, E. Ivanova, N. Komarova, D. Pishiniyi, P. Vorobjev, V. Zarytova, S. Zaramella, F.M. Veronese, Biological properties of antisense oligonucleotides conjugated to different high-molecular mass poly(ethylen glycols), Nucleosides Nucleotides (1999) in press.
12. M. Matsukura, K. Shinozouka, G. Zon, H. Mitsuya, M. Reitz, J.S. Cohen, S. Broder, Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus, Proc. Natl. Acad. Sci. USA 84 (1987) 7706-7710.
13. G.M. Bonora, S. Zaramella, F.M. Veronese, Synthesis by high-efficiency liquid-phase (HELP) method of oligonucleotides conjugated with high-molecular weight polyethylene glycols (PEGs), Biol. Proced. Online 1 (1998) at www.science.uwaterloo.ca/bpo.
14. B. Burcovich, F.M. Veronese, V. Zarytova, G.M. Bonora, Branched polyethylene glycol (bPEG) conjugated antisense oligonucleotides, Nucleosides Nucleotides 17 (1998) 1567-1570.